Previous studies investigating the genomic landscape of NSCLC in ever versus never smokers found a similar pattern to our data, with EGFR mutations more frequent in never smokers, and TP53 and KRAS more commonly mutated in ever smokers.5 This evidence concerns the gene KRAS and non-small cell lung carcinoma.